Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Graphene Can Also Function As MRI Contrast Agent

By Daniel Beris
Posted on 01 Dec 2016
Image: Fluorinated graphene oxide quantum dots could serve as a non-toxic MRI contrast agent (Photo courtesy of Jeff Fitlow/Rice University).
Image: Fluorinated graphene oxide quantum dots could serve as a non-toxic MRI contrast agent (Photo courtesy of Jeff Fitlow/Rice University).
Metal-free fluorinated graphene may soon find a new use as a contrast agent for magnetic resonance imaging (MRI), according to a new study.

Developed by researchers at Rice University (Rice, Houston, TX, USA), the Indian Institute of Science (Bangalore), and other institutions, the metal-free, dual modal contrast agents are based on fluorographene quantum dots, nanoparticle disks of graphene that are decorated with fluorine atoms and organic molecules to make them magnetic. The nanoparticles can be manufactured in less than a day, using micron-sized sheets of fluorinated and oxidized graphene.

When the sheets are added to a solvent and stirred for several hours, they break into smaller pieces, or dots. According to the researchers, the fluorographene quantum dots could be particularly useful as MRI contrast agents because they could be targeted to specific kinds of tissue. An additional advantage is that since the dots are composed of carbon, hydrogen, oxygen, and fluorine, there are no signs of toxicity, as evidenced by cell culture tests. The study was published on October 21, 2016, in Particle and Particle Systems Characterization.

“There are tried-and-true methods for attaching biomarkers to carbon nanoparticles, so one could easily envision using these quantum dots to develop tissue-specific contrast agents,” said senior author Professor Pulickel Ajayan, PhD, of Rice University. “For example, this method could be used to selectively target specific types of cancer or brain lesions caused by Alzheimer’s disease. That kind of specificity isn’t available with today’s contrast agents.”

“We worked with a team from MD Anderson cancer center to assess the cytocompatibility of fluorinated graphene oxide quantum dots,” added lead author Sruthi Radhakrishnan, MSc, a graduate student at the Rice department of materials science and nanoengineering. “We used a test that measures metabolic activity of cell cultures and detects toxicity as a drop in metabolic activity. We incubated quantum dots in kidney cell cultures for up to three days and found no significant cell death in the cultures, even at the highest concentrations.”

Related Links:
Rice University
Indian Institute of Science
Half Apron
Demi
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Digital Radiographic System
OMNERA 300M
MRI System
nanoScan MRI 3T/7T

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.